OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
OptimizeRx (Nasdaq: OPRX) will hold a third quarter 2025 conference call on Thursday, November 6, 2025 at 4:30 p.m. ET to discuss results for the quarter ended September 30, 2025. Management will host the call, followed by Q&A. Financial results will be released in a press release prior to the call.
Call access includes toll-free and international numbers, a Call Me link and a live webcast; a replay will be available for 12 months on the company investor website.
OptimizeRx (Nasdaq: OPRX) terrà una conference call del terzo trimestre 2025 giovedì 6 novembre 2025 alle 16:30 ET per discutere i risultati del trimestre chiuso al 30 settembre 2025. Il management ospiterà la chiamata, seguita da una sessione di domande e risposte. I risultati finanziari saranno annunciati in un comunicato stampa prima della chiamata.
L'accesso alla chiamata include numeri gratuiti e internazionali, un link Call Me e una trasmissione in diretta; una replica sarà disponibile per 12 mesi sul sito degli investitori dell'azienda.
OptimizeRx (Nasdaq: OPRX) celebrará una llamada de conferencia del tercer trimestre de 2025 el jueves 6 de noviembre de 2025 a las 4:30 p.m. hora del Este para discutir los resultados del trimestre finalizado el 30 de septiembre de 2025. La gerencia dirigirá la llamada, seguida de una sesión de preguntas y respuestas. Los resultados financieros se publicarán en un comunicado de prensa antes de la llamada.
El acceso a la llamada incluye números gratuitos e internacionales, un enlace Call Me y una transmisión en vivo; habrá una reproducción disponible durante 12 meses en el sitio web de inversionistas de la empresa.
OptimizeRx (Nasdaq: OPRX)는 2025년 3분기 컨퍼런스 콜을 2025년 11월 6일 목요일 동부 표준시 16:30에 개최하여 2025년 9월 30일 종료 분기의 실적을 논의합니다. 경영진이 콜을 진행하고 이어서 Q&A가 진행됩니다. 실적은 콜 전에 보도자료로 발표됩니다.
콜 접속에는 무료 및 국제 전화번호, Call Me 링크, 실시간 웹캐스트가 포함되며, 회사의 투자자 웹사이트에서 12개월 동안 재생됩니다.
OptimizeRx (Nasdaq : OPRX) tiendra une conférence téléphonique sur le troisième trimestre 2025 le jeudi 6 novembre 2025 à 16 h 30, heure de l’Est pour discuter des résultats du trimestre clos le 30 septembre 2025. La direction animera l’appel, suivie d’une session de questions-réponses. Les résultats financiers seront publiés dans un communiqué de presse avant l’appel.
L’accès à l’appel comprend des numéros gratuits et internationaux, un lien Call Me et une diffusion en direct; une rediffusion sera disponible pendant 12 mois sur le site des investisseurs de l’entreprise.
OptimizeRx (Nasdaq: OPRX) wird einen Conference Call zum dritten Quartal 2025 am Donnerstag, den 6. November 2025 um 16:30 Uhr ET abhalten, um die Ergebnisse für das Quartal zum 30. September 2025 zu besprechen. Die Geschäftsführung wird den Call moderieren, gefolgt von einer Fragerunde. Die Finanzergebnisse werden vor dem Call in einer Pressemitteilung veröffentlicht.
Der Call-Zugang umfasst kostenlose und internationale Nummern, einen Call Me-Link und einen Live-Webcast; eine Wiederholung wird für 12 Monate auf der Investorenseite des Unternehmens verfügbar sein.
ستعقد OptimizeRx (بورصة ناسداك: OPRX) مكالمة هاتفية حول الربع الثالث من عام 2025 يوم الخميس 6 نوفمبر 2025 في الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة لمناقشة نتائج الربع المنتهي في 30 سبتمبر 2025. ستستضيف الإدارة المكالمة، تليها جلسة أسئلة وأجوبة. سيتم إصدار النتائج المالية في بيان صحفي قبل المكالمة.
يتضمن وصول الاتصال أرقام مجانية ورقمية دولية، ورابط Call Me وبث مباشر؛ ستكون هناك إعادة بث متاح لمدة 12 شهرًا على موقع المستثمرين الخاص بالشركة.
OptimizeRx（纳斯达克股票代码：OPRX）将于 2025 年 11 月 6 日（星期四）美国东部时间下午 4:30 举行 2025 年第三季度电话会议，讨论截至 2025 年 9 月 30 日的季度业绩。管理层将主持电话，随后进行问答环节。财务业绩将先通过新闻稿发布。
电话接入包括免费和国际号码、Call Me 链接以及实时网络广播；公司投资者网站将提供为期 12 个月的回放。
- None.
- None.
WALTHAM, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, will hold a conference call on Thursday, November 6, 2025, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2025. The financial results will be issued in a press release prior to the call.
OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:
| Date: | Thursday, November 6, 2025 |
| Time: | 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) |
| Toll Free: | 1-844-825-9789 |
| International: | 1-412-317-5180 |
| Conference ID: | 10203796 |
| Call me™ Link: | https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg== |
| Call me™ Passcode: | 1758869 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1738663&tp_key=cbe79a5b8d |
Please call the conference telephone number or log on to the web access link five minutes prior to the start time.
A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at http://www.optimizerx.com/investors.
About OptimizeRx
OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.
For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com.
OptimizeRx Contact
Andy D’Silva, Chief Business Officer
adsilva@optimizerx.com
Investor Relations Contact
Steven Halper
LifeSci Advisors, LLC
shalper@lifesciadvisors.com
FAQ
When is OptimizeRx's OPRX third quarter 2025 conference call scheduled?
How can investors listen to the OptimizeRx (OPRX) Q3 2025 earnings call?
Will OptimizeRx release financial results before the November 6, 2025 call?
Is there a replay of the OptimizeRx OPRX Q3 2025 call and where is it available?
What is the conference ID and passcode for the OptimizeRx November 6, 2025 call?
What time is the OptimizeRx call in Pacific Time on November 6, 2025?
